🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will evaluate the effects of itraconazole (Part A) and, carbamaz...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-27
Trial ID
NCT07775261
Treatments Being Tested
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
This study will be a single center, open-label, drug-drug interaction study...
Status
Completed
Location
PPD Development LLC
Start Date
2014-02
Trial ID
NCT02085967
Treatments Being Tested
This study described in the present protocol consists of two parts. Part A ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-01
Trial ID
NCT01209039
Treatments Being Tested
This 5-part study will evaluate the safety, tolerability, and pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00990821
This is a study to evaluate the safety, tolerability and pharmacokinetics o...
Status
Completed
Location
Atlanta Center for Medical Research - Sickle Cell Subjects Only
Start Date
2020-10-26
Trial ID
NCT04586985
The main purpose of this study in healthy participants is to learn more abo...
Status
Terminated
Location
Anaheim Clinical Trials, LLC
Start Date
2020-10-20
Trial ID
NCT04586920
Treatments Being Tested
THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2017-08-15
Trial ID
NCT03016819
The purpose of this study is to evaluate the pharmacokinetics (PK), drug-dr...
Status
Completed
Location
MAC Clinical Research
Start Date
2024-05-02
Trial ID
NCT06392659
Treatments Being Tested
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613